Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)

NCT04924660 is registered in ClinicalTrials.gov with Sean Collins as lead sponsor.

NCT NCT04924660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04924660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
Lead sponsor
Sean Collins
Phase
Phase 2/3
Overall status
Completed
Start date
July 15, 2021
Completion date
December 31, 2023
Enrollment
1,060 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid-19, sars-cov-2 infection